Serum prohepcidin in pulmonary tuberculosis

Hematology

Volumn 14, Issue 4, 2009, Pages 245-248

  Kaplan, Mustafa ^a   Erikci, Alev Akyol ^a   Ozturk, Ahmet ^a   Kirilmaz, Ata ^a   Tas, Dilaver ^a   Ciftci, Faruk ^a   Kartaloglu, Zafer ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

Anemia of chronic disease; Prohepcidin; Pulmonary tuberculosis

Indexed keywords

ETHAMBUTOL; HEPCIDIN; ISONIAZID; MORINAMIDE; RIFAMPICIN; ANTIMICROBIAL CATIONIC PEPTIDE; BIOLOGICAL MARKER; PROHEPCIDIN; PROTEIN PRECURSOR;

ADULT; ANEMIA; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE MARKER; HUMAN; LUNG TUBERCULOSIS; MALE; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SPUTUM SMEAR; TREATMENT RESPONSE; BLOOD; CASE CONTROL STUDY; MICROBIOLOGY;

ADULT; ANEMIA; ANTIMICROBIAL CATIONIC PEPTIDES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; HUMANS; MALE; PROTEIN PRECURSORS; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 70349929371     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/102453309X439764     Document Type: Article

References (10)

1. Jurado RL. Iron, infections, and anemia of inflammation. Clin Infect Dis 1997; 25: 888-895.
2. Park CH, Valore EV, Waring AJ, Ganz T, Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001; 276: 7806-7810.
3. Ganz T. Hepcidin and its role in regulating systemic iron metabolism. Hematology Am Soc Hematol Educ Program 2006; 29-35: 507.
4. Ganz T. Molecular control of iron transport. J Am Soc Nephrol 2007; 18: 394-400.
5. Ganz T. Iron homeostasis: fitting the puzzle pieces together. Cell Metab 2008; 7: 288-290.
6. Andrews NC, The iron transporter DMT1. Int J Biochem Cell Biol 1999; 31: 991-994.
7. Malyszko J, Malyszko JS, Hryszko T, Pawlak K, Mysliwiec M. Is hepcidin a link between anemia, inflammation and liver function in hemodialyzed patients? Am J Nephrol 2005; 25: 586-590.
8. Malyszko J, Malyszko JS, Pawlak K, Mysliwiec M. Hepcidin, iron status, and renal function in chronic renal failure, kidney transplantation, and hemodialysis. Am J Hematology 2006; 81: 832-837.
9. Oguz A, Uzunlulu M, Hekim N. Hepcidin is a not marker of chronic inflammation in atherosclerosis. Anadol Kardiyol Derg 2006; 6: 239-242.
10. Malyszko J, Malyszko JS, Pawlak K, Mysliwiec M. Hepcidin, an acute-phase protein and a marker of inflammation in kidney transplant recipients with and without coronary artery disease. Transplant Proc 2006; 38: 2895-2898.